shadow_tr

Leukemia
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Acute Leukemia


S0919
A Phase II Study of Idarubicin and Ara-C in Combination with Pravastatin for Relapsed Acute Myelogenous Leukemia
More Information

CC-486-AML-001
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Compare Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Subjects with Acute Myeloid Leukemia in Complete Remission
More Information

ASTELLAS
A Phase 3 Open-Label, Multicenter, Randomized Study of ASP2215 versus Salvage Chemotherapy in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) with FLT3 Mutation
More Information

Chronic Leukemia

BMT 2000-1
(CML in the 1st Chronic Phase) Allogeneic Bone Marrow Transplantation for Chronic Myelogenous Leukemia using Primed Bone Marrow Stem Cells

TETRALOGIC
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Azacitidine With or Without Birinapant With a Single Arm Open-Label Run-In Phase Subjects With Higher Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
More Information

ACERTA
A Randomized, Multicenter, Open-Label, 3 Arm Phase 3 Study of Obinutuzumab in Combination With Chlorambucil, ACP-196 in Combination with Obinutuzumab, and ACP-196 Monotherapy in Subjects with Previously Untreated Chronic Lymphocytic Leukemia
More Information

1430 Tulane Ave, New Orleans, LA 70112 504-988-5251 physiology@wave.tulane.edu